Venous Thromboembolism Concept

subject area of

• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer  Academic Article
• 2019 international clinical practice guidelines for the treatment of venous thromboembolism – Authors' reply  Academic Article
• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19  Academic Article
• 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE  Academic Article
• d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism  Academic Article
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Academic Article
• A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery  Academic Article
• A Case of a Pediatric Patient With Protein S Heerlen Polymorphism and Deep Venous Thrombosis  Academic Article
• A Device on Trial — Intermittent Pneumatic Compression in Critical Care  Academic Article
• A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures  Academic Article
• A Genome-Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium  Academic Article
• A Population-Based Study of Inferior Vena Cava Filters in Patients With Acute Venous Thromboembolism  Academic Article
• A Test in Context: D-Dimer  Academic Article
• A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty  Academic Article
• A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery  Academic Article
• A logical approach to surgical thromboprophylaxis  Academic Article
• A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients  Academic Article
• A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients  Academic Article
• A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment  Academic Article
• A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin  Academic Article
• A response to–There’s madness in their methods  Academic Article
• A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal  Academic Article
• A user guide to the American Society of Hematology clinical practice guidelines  Academic Article
• ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery  Academic Article
• ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease  Academic Article
• ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients?  Academic Article
• ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America  Academic Article
• ASO Author Reflections: Post-Discharge Venous Thromboembolism Incidence and Risk Factors  Academic Article
• AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study  Academic Article
• Abelacimab for Prevention of Venous Thromboembolism  Academic Article
• Abelacimab for Prevention of Venous Thromboembolism  Academic Article
• Accumulating data on rivaroxaban for venous thromboembolism in clinical practice  Academic Article
• Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals  Academic Article
• Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants  Academic Article
• Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria  Academic Article
• Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis  Academic Article
• Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study  Academic Article
• Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis  Academic Article
• Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis  Academic Article
• Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis  Academic Article
• Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents  Academic Article
• Advances in the management of venous thromboembolism.  Academic Article
• Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study  Academic Article
• Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm  Academic Article
• American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ  Academic Article
• American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer  Academic Article
• American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients  Academic Article
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy  Academic Article
• American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients  Academic Article
• American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism  Academic Article
• American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults  Academic Article
• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer  Academic Article
• American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19  Academic Article
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients  Academic Article
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients  Academic Article
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis  Academic Article
• American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients  Academic Article
• American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America  Academic Article
• An International Survey on the Use of Thromboprophylaxis in Urological Surgery  Academic Article
• An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery  Academic Article
• Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial  Academic Article
• Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis  Academic Article
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Academic Article
• Anticoagulation for Mechanical Heart Valves  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Academic Article
• Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients  Academic Article
• Antiphospholipid antibiodies: a critical review of the literature  Academic Article
• Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism  Academic Article
• Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review  Academic Article
• Antiphospholipid antibodies in critical illness  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antiplatelet therapy in prevention of cardio- and venous thromboembolic events  Academic Article
• Antithrombotic therapy in children with venous thromboembolism  Academic Article
• Apixaban for Extended Treatment of Venous Thromboembolism  Academic Article
• Apixaban to Prevent Venous Thromboembolism in Patients with Cancer  Academic Article
• Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement  Academic Article
• Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients  Academic Article
• Apixaban versus Enoxaparin in Medically Ill Patients  Academic Article
• Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial  Academic Article
• Appraisal of: Role of physical therapists in the management of individuals at risk for or diagnosed with venous thromboembolism: evidence-based clinical practice guideline  Academic Article
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Academic Article
• Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.  Academic Article
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Academic Article
• Aspirin for Dual Prevention of Venous and Arterial Thrombosis  Academic Article
• Aspirin for Preventing Venous Thromboembolism  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Academic Article
• Aspirin in secondary prevention of recurrent venous thromboembolism  Academic Article
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Academic Article
• Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial  Academic Article
• Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease  Academic Article
• Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials  Academic Article
• Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode  Academic Article
• Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials  Academic Article
• Association of Venous Thromboembolism With Hormonal Contraception and Thrombophilic Genotypes  Academic Article
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Academic Article
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation  Academic Article
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism  Academic Article
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism  Academic Article
• Avancées récentes en médecine interne  Academic Article
• Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach  Academic Article
• Balancing the Risks and Benefits of Thromboprophylaxis in Patients Undergoing Podiatric Surgery  Academic Article
• Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers  Academic Article
• Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study  Academic Article
• Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis  Academic Article
• Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty  Academic Article
• Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials  Academic Article
• Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin  Academic Article
• Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness  Academic Article
• Berzelius Symposium 93: International Conference on Thrombosis and Embolism  Academic Article
• Betrixaban (PRT054021): pharmacology, dose selection and clinical studies  Academic Article
• Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores  Academic Article
• Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors  Academic Article
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Academic Article
• Bleeding events with dabigatran or warfarin in patients with venous thromboembolism  Academic Article
• Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation  Academic Article
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Academic Article
• Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment  Academic Article
• CORR Insights®: High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study  Academic Article
• Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE  Academic Article
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Academic Article
• Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty  Academic Article
• Certainty ranges facilitated explicit and transparent judgments regarding evidence credibility  Academic Article
• Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry  Academic Article
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Academic Article
• Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism  Academic Article
• Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials  Academic Article
• Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism  Academic Article
• Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study  Academic Article
• Clinical implications of incidental venous thromboembolism in cancer patients  Academic Article
• Clinical implications of reversal agents for direct oral anticoagulants  Academic Article
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Academic Article
• Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study  Academic Article
• Clinical probability score and D‐dimer estimation lack utility in the diagnosis of childhood pulmonary embolism  Academic Article
• Combined Modalities in Surgical Patients  Academic Article
• Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease  Academic Article
• Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE  Academic Article
• Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study  Academic Article
• Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)  Academic Article
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Academic Article
• Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy  Academic Article
• Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism  Academic Article
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Academic Article
• Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients  Academic Article
• Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism  Academic Article
• Compression stockings for preventing the postthrombotic syndrome in patients with deep vein thrombosis  Academic Article
• Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology  Academic Article
• Contribution of indirect computed tomographic venography to the diagnosis of postpartum venous thromboembolism  Academic Article
• Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism  Academic Article
• Cost-Effectiveness of Prevention and Treatment of VTE  Academic Article
• Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients  Academic Article
• Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review  Academic Article
• Current strategies in prophylaxis and treatment of venous thromboembolism  Academic Article
• D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders  Academic Article
• D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment  Academic Article
• DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines  Academic Article
• Dabigatran Etexilate  Academic Article
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Academic Article
• Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management  Academic Article
• Dabigatran etexilate for prevention of venous thromboembolism  Academic Article
• Dabigatran in clinical practice: Contemporary overview of the evidence  Academic Article
• Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial  Academic Article
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.  Academic Article
• Dabigatran versus Warfarin for Venous Thromboembolism  Academic Article
• Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism  Academic Article
• Dabigatran: ready for prime time?  Academic Article
• Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)  Academic Article
• Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol  Academic Article
• Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury  Academic Article
• Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009)  Academic Article
• Deep Vein Thrombosis Prophylaxis in Hospitalized Medical Patients: Current Recommendations, General Rates of Implementation, and Initiatives for Improvement  Academic Article
• Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH  Academic Article
• Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin “flushes”  Academic Article
• Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines  Academic Article
• Development of a core outcome set for studies on prevention and management of pregnancy-associated venous thromboembolism (COSPVenTE): a study protocol  Academic Article
• Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation  Academic Article
• Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial  Academic Article
• Differences in the safety profiles of two low-molecular-weight heparins  Academic Article
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Academic Article
• Direct oral anticoagulants after bariatric surgery—What is the evidence?  Academic Article
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Academic Article
• Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis  Academic Article
• Direct oral anticoagulants: evidence and unresolved issues  Academic Article
• Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?  Academic Article
• Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?  Academic Article
• Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism  Academic Article
• Dosing Frequency of Unfractionated Heparin Thromboprophylaxis  Academic Article
• Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism  Academic Article
• Duration of anticoagulant therapy for venous thromboembolism  Academic Article
• Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials  Academic Article
• D‐dimer testing is useful to exclude deep vein thrombosis in elderly outpatients  Academic Article
• ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism  Academic Article
• Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy  Academic Article
• Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Editorial Commentary: A Patient-Specific Approach to Preventing Venous Thromboembolism After Hip Arthroscopy Is Essential  Academic Article
• Editorial Commentary: Don't Worry About It—Hip Arthroscopy Is Safe From Venous Thromboembolism…Mostly Yes!  Academic Article
• Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease  Academic Article
• Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism  Academic Article
• Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer  Academic Article
• Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study  Academic Article
• Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial  Academic Article
• Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism  Academic Article
• Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism  Academic Article
• Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty  Academic Article
• Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature  Academic Article
• Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis  Academic Article
• Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography  Academic Article
• Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism  Academic Article
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Academic Article
• Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state  Academic Article
• Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism  Academic Article
• Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism  Academic Article
• Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials  Academic Article
• Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants  Academic Article
• Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism  Academic Article
• Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients  Academic Article
• Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19  Academic Article
• Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis  Academic Article
• Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis  Academic Article
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Academic Article
• Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty  Academic Article
• Ethnoracial variations in venous thrombosis: Implications for management, and a call to action  Academic Article
• Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants  Academic Article
• Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project  Academic Article
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis  Academic Article
• Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study  Academic Article
• Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients  Academic Article
• Evidence and Clinical Judgment: Vena cava filters  Academic Article
• Evolving use of new oral anticoagulants for treatment of venous thromboembolism  Academic Article
• Extended Anticoagulation in Venous Thromboembolism  Academic Article
• Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis  Academic Article
• Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients  Academic Article
• Extended Treatment of Venous Thromboembolism  Academic Article
• Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism  Academic Article
• Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review  Academic Article
• Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended anticoagulation in venous thromboembolism.  Academic Article
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review  Academic Article
• Extended treatment of venous thromboembolism.  Academic Article
• Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study  Academic Article
• Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study  Academic Article
• Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis  Academic Article
• Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility  Academic Article
• Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials  Academic Article
• Extended‐duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta‐analysis of the randomized controlled trials  Academic Article
• Extension of anticoagulation after venous thromboembolism  Academic Article
• External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)  Academic Article
• Extracellular DNA and histones: double‐edged swords in immunothrombosis  Academic Article
• Factor XI inhibitors: what should clinicians know  Academic Article
• Factor Xa and thrombin as targets for new oral anticoagulants  Academic Article
• Factors Associated With Adverse Outcomes in Outpatients Presenting With Pulmonary Embolism  Academic Article
• Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism  Academic Article
• Factors that predict thrombosis in relatives of patients with venous thromboembolism  Academic Article
• Failure of Anticoagulant Thromboprophylaxis  Academic Article
• Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban  Academic Article
• Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial  Academic Article
• Frequency of arterial thromboembolism in populations with malignancies: A systematic review  Academic Article
• Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study  Academic Article
• General, Vascular, Bariatric, and Plastic Surgical Patients  Academic Article
• Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE)  Academic Article
• Global public awareness of venous thromboembolism  Academic Article
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Academic Article
• Graduated compression stockings to prevent venous thromboembolism in hospital. Evidence from patients with acute stroke  Academic Article
• Guidance for the treatment and prevention of obstetric-associated venous thromboembolism  Academic Article
• Guidance, guidelines, and communications  Academic Article
• Guideline of guidelines: thromboprophylaxis for urological surgery  Academic Article
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Academic Article
• Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU  Academic Article
• Gynecology and Obstetrics  Academic Article
• HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE  Academic Article
• Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis  Academic Article
• Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment  Academic Article
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Academic Article
• Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene  Academic Article
• High Variation Between Hospitals in Vena Cava Filter Use for Venous Thromboembolism  Academic Article
• High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients  Academic Article
• High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome  Academic Article
• Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis  Academic Article
• Hospitalized COVID-19 Patients and Venous Thromboembolism  Academic Article
• How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism  Academic Article
• How I treat heavy menstrual bleeding associated with anticoagulants  Academic Article
• How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy  Academic Article
• How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized?  Academic Article
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Academic Article
• How do we manage venous thromboembolism in pregnancy? A retrospective review of the practice of diagnosing and managing pregnancy-related venous thromboembolism at two major hospitals in Australia and New Zealand  Academic Article
• How long is long enough for pharmacological thromboprophylaxis in urology?  Academic Article
• How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines  Academic Article
• Human-Derived D-Dimer for External Quality Assessment  Academic Article
• Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism  Academic Article
• Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy  Academic Article
• Impact of ABO Blood Group on the Development of Venous Thromboembolism in Children With Cancer: A Systematic Review and Meta-Analysis  Academic Article
• Impact of Inherited Thrombophilia on Venous Thromboembolism in Children  Academic Article
• Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE  Academic Article
• Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients  Academic Article
• Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial  Academic Article
• Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis  Academic Article
• Impact of thrombophilia screening on venous thromboembolism management practices  Academic Article
• Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement  Academic Article
• Importance of Family History as a Risk Factor for Venous Thromboembolism  Academic Article
• Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative  Academic Article
• In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days  Academic Article
• In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 mo  Academic Article
• Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study  Conference Paper
• Incidence of delayed venous thromboembolic events in patients undergoing abdominal and pelvic surgery for cancer: a systematic review and meta‐analysis  Academic Article
• Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer  Academic Article
• Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study  Academic Article
• Indications, Complications, and Management of Inferior Vena Cava Filters  Academic Article
• Inferior Vena Cava Filters to Prevent Pulmonary Embolism  Academic Article
• Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials  Academic Article
• Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial  Academic Article
• International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis  Academic Article
• International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer  Academic Article
• Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism  Academic Article
• Introduction  Academic Article
• Is pretest probability assessment on emergency department patients with suspected venous thromboembolism documented before SimpliRED D-dimer testing?  Conference Paper
• Is venous thromboembolism a preventable cause of death?  Academic Article
• Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry  Academic Article
• Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study  Academic Article
• JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis  Academic Article
• Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery  Academic Article
• Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery  Academic Article
• Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants  Academic Article
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Academic Article
• Less menorrhagia for women with VTE  Academic Article
• Letter  Academic Article
• Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels  Academic Article
• Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Academic Article
• Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis  Academic Article
• Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials  Academic Article
• Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism  Academic Article
• Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis  Academic Article
• Long-term Follow-up of the Implementation of a Venous Thromboembolism Prophylaxis Order Set on a Cardiology Ward: Still a Surprising Result?  Academic Article
• Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis  Academic Article
• Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study  Academic Article
• Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study  Academic Article
• Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis  Academic Article
• Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial  Academic Article
• Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism  Academic Article
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Academic Article
• Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture  Academic Article
• Low-molecular-weight heparin in patients with chronic renal insufficiency  Academic Article
• Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review  Academic Article
• Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial  Academic Article
• Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review  Academic Article
• Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials  Academic Article
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Academic Article
• Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting  Academic Article
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Academic Article
• Management of Pregnant Women with Thrombophilia or a History of Venous Thromboembolism  Academic Article
• Management of bleeding complications in patients with cancer on DOACs  Academic Article
• Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease  Academic Article
• Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey  Academic Article
• Management of recurrent venous thromboembolism in patients with cancer: A review  Academic Article
• Management of venous thromboembolism in patients with cancer: role of dalteparin  Academic Article
• Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE  Academic Article
• Managing challenging patients with venous thromboembolism: a practical, case-based approach  Academic Article
• Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?  Academic Article
• Media portrayals of pulmonary embolism  Academic Article
• Medical Patients  Academic Article
• Medical prophylaxis: the value of an “opt in” policy  Academic Article
• Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery  Academic Article
• Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context  Academic Article
• Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences  Academic Article
• Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2  Academic Article
• Milvexian for the Prevention of Venous Thromboembolism  Academic Article
• Mortality benefits of thromboprophylaxis  Academic Article
• NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank  Academic Article
• NOACs for treatment of venous thromboembolism in clinical practice  Academic Article
• Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis  Academic Article
• Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease  Academic Article
• Navigating the anticoagulant landscape in 2017  Academic Article
• Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™  Academic Article
• Neurosurgery  Academic Article
• New Anticoagulants for Treatment of Venous Thromboembolism  Academic Article
• New Anticoagulants for the Prevention of Thromboembolism  Academic Article
• New Antithrombotic Drugs: Potential for Use in Oncology  Academic Article
• New aspects on treatment modalities for thromboembolic episodes  Academic Article
• New developments in anticoagulants: Past, present and future  Academic Article
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Academic Article
• New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty  Academic Article
• New oral anticoagulants in elderly patients  Academic Article
• New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?  Academic Article
• New oral anticoagulants: not quite there yet  Academic Article
• Newer Anticoagulants in Critically Ill Patients  Academic Article
• No apparent association between mRNA COVID-19 vaccination and venous thromboembolism  Academic Article
• No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception  Academic Article
• Non-OO blood type influences the risk of recurrent venous thromboembolism  Academic Article
• Nonleg Venous Thrombosis in Critically Ill Adults  Conference Paper
• Novel antithrombotic strategies for treatment of venous thromboembolism  Academic Article
• Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study  Academic Article
• Optimal Duration of Anticoagulant Therapy  Academic Article
• Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants  Academic Article
• Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis  Academic Article
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Academic Article
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Academic Article
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Academic Article
• Oral contraceptive use is a provoking factor for venous thromboembolism  Academic Article
• Oral contraceptives and the risk of venous thromboembolism: An update  Academic Article
• Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis  Academic Article
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Academic Article
• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement  Academic Article
• Orthopedic Surgery and Trauma  Academic Article
• Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours  Academic Article
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Academic Article
• Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns  Academic Article
• P-selectin ready for prime time?  Academic Article
• PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in ambulatory patients with cancer  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Academic Article
• Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study  Academic Article
• Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment  Academic Article
• Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines  Academic Article
• Patient- and Health-Care-Provider-Reported Outcomes to Consider in Research on Pregnancy-Associated Venous Thromboembolism  Academic Article
• Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism  Academic Article
• Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences  Academic Article
• Patients With Cancer  Academic Article
• Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism  Academic Article
• Perioperative Aspirin for Prevention of Venous Thromboembolism  Academic Article
• Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation  Academic Article
• Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes  Academic Article
• Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients  Academic Article
• Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism  Academic Article
• Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis  Academic Article
• Pharmacoprophylaxis for Venous Thromboembolism in Spinal Surgery: A Systematic Review and Meta-analysis  Academic Article
• Pneumatic Compression in Venous Thromboprophylaxis  Academic Article
• Polish guidelines for the prevention and treatment of venous thromboembolism 2009 update  Academic Article
• Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery  Academic Article
• Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients  Academic Article
• Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin  Academic Article
• Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey  Academic Article
• Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study  Academic Article
• Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)  Academic Article
• Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study  Academic Article
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment  Academic Article
• Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study  Academic Article
• Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001  Academic Article
• Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment  Academic Article
• Pregnancy-related venous thromboembolism: Progress but questions remain  Academic Article
• Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery  Academic Article
• Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE  Academic Article
• Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model  Academic Article
• Prevalence of venous thromboembolism after lung surgery in China: a single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis†  Academic Article
• Preventing Venous Thromboembolism in Critically Ill Patients  Academic Article
• Preventing thrombophilia-related complications of pregnancy  Academic Article
• Preventing thrombophilia-related complications of pregnancy: an update  Academic Article
• Preventing venous thromboembolism in long-term care residents: Cautious advice based on limited data  Academic Article
• Prevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach  Academic Article
• Prevention and treatment of venous thromboembolism during pregnancy  Academic Article
• Prevention and treatment of venous thromboembolism in the elderly patient.  Academic Article
• Prevention and treatment of venous thromboembolism--International Consensus Statement.  Academic Article
• Prevention of VTE in Orthopedic Surgery Patients  Academic Article
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Academic Article
• Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review  Academic Article
• Prevention of thrombosis in antiphospholipid syndrome  Academic Article
• Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions  Academic Article
• Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?  Academic Article
• Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review  Academic Article
• Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)  Academic Article
• Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis  Academic Article
• Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis  Academic Article
• Procoagulant effects of lung cancer chemotherapy  Academic Article
• Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism  Academic Article
• Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis  Academic Article
• Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis  Academic Article
• Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis  Academic Article
• Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence‑based and practical approach  Academic Article
• Prophylaxis against venous thromboembolism in neurointensive care patients: Survey of Canadian practice  Academic Article
• Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.  Academic Article
• Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study  Academic Article
• Prophylaxis for preventing venous thromboembolism in knee arthroscopy and soft tissue reconstruction: consensus statements from an international panel of experts  Academic Article
• Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society  Academic Article
• Prophylaxis of venous thromboembolism in elderly patients with multimorbidity  Academic Article
• Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults  Academic Article
• Protocol implementation for venous thromboembolism prophylaxis: a before-and-after study in medical and surgical patients  Academic Article
• Pulmonary Embolism in Pregnancy  Academic Article
• Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies  Academic Article
• Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply  Academic Article
• Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: reply  Academic Article
• RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate  Academic Article
• RETIRED: Oral Contraceptives and the Risk of Venous Thromboembolism: An Update  Academic Article
• Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis  Academic Article
• Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa in Men With Castration-Resistant Prostate Cancer and Anemia  Academic Article
• Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study  Academic Article
• Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding  Academic Article
• Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery  Academic Article
• Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens  Academic Article
• Recent Advances in Thrombosis and Hemostasis—Part II  Academic Article
• Recent advances in understanding, diagnosing and treating venous thrombosis  Academic Article
• Recommendations for prophylaxis of pregnancy‐related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal  Academic Article
• Recommendations for standardized risk factor definitions in pediatric hospital‐acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH  Academic Article
• Recommendations for the assessment of non‐extremity venous thromboembolism outcomes: communication from the SSC of the ISTH  Academic Article
• Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH  Academic Article
• Recommendations from the ICM-VTE: Oncology  Academic Article
• Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis  Academic Article
• Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis  Academic Article
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Academic Article
• Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism  Academic Article
• Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary  Academic Article
• Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis  Academic Article
• Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?  Academic Article
• Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care  Academic Article
• Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study  Academic Article
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Academic Article
• Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin”  Academic Article
• Response.  Academic Article
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions  Academic Article
• Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants  Academic Article
• Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit  Academic Article
• Risk and complications of venous thromboembolism in dialysis patients  Academic Article
• Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review  Academic Article
• Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban  Academic Article
• Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism  Academic Article
• Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment  Academic Article
• Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor  Academic Article
• Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR  Academic Article
• Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data  Academic Article
• Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis  Academic Article
• Risk of recurrent venous thromboembolism according to baseline risk factor profiles  Academic Article
• Risk of recurrent venous thromboembolism after a first oestrogen-associated episode  Academic Article
• Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting  Academic Article
• Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage  Academic Article
• Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews  Academic Article
• Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review  Academic Article
• Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis  Academic Article
• Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization  Academic Article
• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial  Academic Article
• Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions  Academic Article
• Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial  Academic Article
• Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness  Academic Article
• Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer  Academic Article
• Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older  Academic Article
• Rivaroxaban for prevention and treatment of venous thromboembolism  Academic Article
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Academic Article
• Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation  Academic Article
• Rivaroxaban in Orthopedic Surgery — A Change of Paradigm?  Academic Article
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Academic Article
• Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty  Academic Article
• Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study  Academic Article
• Rofecoxib does not appear to increase the risk of venous thromboembolism: A systematic review of the literature  Academic Article
• Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients  Academic Article
• Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials  Academic Article
• Routine heparin for patients with cancer? One answer, more questions  Academic Article
• SR123781A: A New Once-Daily Synthetic Oligosaccharide Anticoagulant for Thromboprophylaxis After Total Hip Replacement Surgery  Academic Article
• Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups  Academic Article
• Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study  Academic Article
• Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19  Academic Article
• Screening and Prevention of Venous Thromboembolism in Critically Ill Patients  Academic Article
• Screening for Occult Cancer in Unprovoked Venous Thromboembolism  Academic Article
• Secondary prevention of venous thromboembolism  Academic Article
• Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009)  Academic Article
• Selection Bias, Orthopaedic Style  Academic Article
• Selective factor Xa inhibition for thromboprophylaxis  Academic Article
• Selectived-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis  Academic Article
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Academic Article
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE  Academic Article
• Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE  Academic Article
• Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study  Academic Article
• Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis  Academic Article
• Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism?  Academic Article
• Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?  Academic Article
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Academic Article
• Side-Effects of COVID-19 on Patient Care: An INR Story  Academic Article
• Smoking  Academic Article
• State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism  Academic Article
• Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies  Academic Article
• Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial  Academic Article
• Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial  Academic Article
• Structure and function of a perioperative anticoagulation management clinic  Academic Article
• Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes  Academic Article
• Supportive Care in Pediatric Cancer: The Road to Prevention of Thrombosis  Academic Article
• Surveillance duplex scanning to prevent venous thromboembolism: does it make a difference in rehabilitation unit patients?  Academic Article
• Surveillance or no surveillance ultrasonography for deep vein thrombosis and outcomes of critically ill patients: a pre-planned sub-study of the PREVENT trial  Academic Article
• Survey of pharmacologic thromboprophylaxis in critically ill children*  Academic Article
• Symptomatic Venous Thromboembolism Uncommon without Thromboprophylaxis After Isolated Lower-Limb Fracture  Academic Article
• Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism  Academic Article
• Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism  Academic Article
• Targeted Gene Sequencing Identifies Variants in the Protein C and Endothelial Protein C Receptor Genes in Patients With Unprovoked Venous Thromboembolism  Academic Article
• Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10  Academic Article
• The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal  Academic Article
• The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis  Academic Article
• The Approach to Heparin-Induced Thrombocytopenia  Academic Article
• The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis  Conference Paper
• The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE  Academic Article
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Academic Article
• The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism  Academic Article
• The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: Outpatient versus inpatient management  Academic Article
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance Reply  Academic Article
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers  Academic Article
• The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients  Academic Article
• The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants  Academic Article
• The absence of `minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios  Academic Article
• The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure  Academic Article
• The effects of rivaroxaban on the complications of surgery after total hip or knee replacement  Academic Article
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Academic Article
• The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH  Academic Article
• The incidence of venous thromboembolism: a prospective, community‐based study in Perth, Western Australia  Academic Article
• The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE  Academic Article
• The long-term risk of cancer in patients with a first episode of venous thromboembolism  Academic Article
• The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients  Academic Article
• The reemergence of aspirin for the prevention of venous thromboembolism.  Academic Article
• The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction  Academic Article
• The risk and prevention of venous thromboembolism in the pregnant traveller  Academic Article
• The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months  Academic Article
• The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding  Academic Article
• The top 4 advances in antithrombotic care in the last year  Academic Article
• The value of clinical practice guidelines in hematology  Academic Article
• The value of novel oral anticoagulants in rural Australia  Academic Article
• The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism  Academic Article
• Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)  Academic Article
• Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum  Academic Article
• Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis  Academic Article
• Thromboprophylaxis After Hip or Knee Arthroplasty  Academic Article
• Thromboprophylaxis after Knee Arthroscopy  Academic Article
• Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study  Academic Article
• Thromboprophylaxis in Patients Receiving Chemotherapy  Academic Article
• Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial  Academic Article
• Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials  Academic Article
• Thrombosis and anticoagulation in the setting of renal or liver disease  Academic Article
• Thrombosis in Children with Acute Lymphoblastic Leukemia Treated at a Tertiary Care Center in Lebanon: Revisiting the Role of Predictive Models  Academic Article
• Thrombosis is associated with inferior survival in multiple myeloma  Academic Article
• Thrombosis: A major contributor to global disease burden  Academic Article
• Tossing a coin or using common sense  Academic Article
• Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies  Academic Article
• Treatment for Patients With Cancer  Academic Article
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Academic Article
• Treatment of Venous Thromboembolism with New Oral Anticoagulants According to Patient Risk  Academic Article
• Treatment of acute pulmonary embolism with dabigatran versus warfarin  Academic Article
• Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management  Academic Article
• Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study  Academic Article
• Treatment of venous thromboembolism with dabigatran  Academic Article
• Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer  Academic Article
• Treatment with novel oral anticoagulants  Academic Article
• Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial  Academic Article
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Academic Article
• Unanswered questions in venous thromboembolism  Academic Article
• Update on the Treatment of Venous Thromboembolism  Academic Article
• Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials  Academic Article
• Use of decision aids for shared decision making in venous thromboembolism: A systematic review  Academic Article
• Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol  Academic Article
• Use of the Delphi method to establish guidelines for treatment of thrombosis  Academic Article
• Using low molecular weight heparin in special patient populations  Academic Article
• Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study  Academic Article
• VTE Prophylaxis in Critically Ill Adults  Academic Article
• VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3  Academic Article
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Validation of a diagnostic approach to exclude recurrent venous thromboembolism  Academic Article
• Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer  Academic Article
• Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries  Academic Article
• Varied opinions on thrombolysis for venous thromboembolism in infants and children: Findings from a survey of pediatric hematology-oncology specialists  Academic Article
• Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study  Academic Article
• Venous Thromboembolism  Chapter
• Venous Thromboembolism Events After Hip Arthroscopy: A Systematic Review  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Academic Article
• Venous Thromboembolism Prophylaxis in Critically Ill Patients  Academic Article
• Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study  Academic Article
• Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination  Academic Article
• Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients  Academic Article
• Venous Thromboembolism in Heart Failure: Preventable Deaths During and After Hospitalization  Academic Article
• Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials  Academic Article
• Venous Thromboembolism in Older Adults: A Community-based Study  Academic Article
• Venous Thromboembolism in Patients Discharged From the Emergency Department With Ankle Fractures: A Population-Based Cohort Study  Conference Paper
• Venous Thromboembolism in Patients With Prior Stroke  Academic Article
• Venous Thromboembolism in Patients With Reduced Estimated GFR: A Population-Based Perspective  Academic Article
• Venous Thromboembolism in Patients with Chronic Obstructive Pulmonary Disease  Academic Article
• Venous Thromboembolism in Patients with Diabetes Mellitus  Academic Article
• Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry  Academic Article
• Venous Thromboembolism in Surgical Lung Cancer Patients: A Provincial Population-Based Study  Conference Paper
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Venous thromboembolism and bleeding in a community setting  Academic Article
• Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE  Academic Article
• Venous thromboembolism in association with features of the metabolic syndrome  Academic Article
• Venous thromboembolism in critical illness in a community intensive care unit  Academic Article
• Venous thromboembolism in patients with symptomatic atherosclerosis  Academic Article
• Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada  Academic Article
• Venous thromboembolism in pregnancy: diagnosis, management and prevention  Academic Article
• Venous thromboembolism in the elderly  Academic Article
• Venous thromboembolism management: where do novel anticoagulants fit?  Academic Article
• Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery  Academic Article
• Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey  Academic Article
• Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting  Academic Article
• Venous thromboembolism, age and hospitalisation: A potentially deadly combination  Academic Article
• Venous thromboembolism: A Call for risk assessment in all hospitalised patients  Academic Article
• Venous thromboembolism: Past, present and future  Academic Article
• Venous thrombosis  Academic Article
• Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism  Academic Article
• Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more  Academic Article
• Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery  Academic Article
• When is it safe to stop for safety?  Academic Article
• Which design for which question? An exploration toward a translation table for comparative effectiveness research  Academic Article
• Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment  Academic Article
• Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study  Academic Article
• Women’s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities  Academic Article
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review  Academic Article
• Wound Disruption Following Caesarean Delivery in Women With Class III Obesity: A Retrospective Observational Study  Conference Paper
• XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America  Academic Article
• [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].  Academic Article